Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age …
See Original Article

Net revenues for Tata Motors’s standalone business were up 15.4% to ₹20,959 crore on a sequential basis in this quarter, due to a 16.5% growth in sales volumes of its passenger cars & commercial vehicles to 200212 units compared to 153480 units the …
See Original Article